Inhibrx Net Income 2020-2022 | INBX
Inhibrx net income from 2020 to 2022. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Inhibrx Annual Net Income (Millions of US $) |
2021 |
$-82 |
2020 |
$-76 |
2019 |
$-51 |
Inhibrx Quarterly Net Income (Millions of US $) |
2022-03-31 |
$-31 |
2021-12-31 |
$-21 |
2021-09-30 |
$-21 |
2021-06-30 |
$-21 |
2021-03-31 |
$-19 |
2020-12-31 |
$-18 |
2020-09-30 |
$-20 |
2020-06-30 |
$-18 |
2020-03-31 |
$-20 |
2019-12-31 |
|
2019-09-30 |
$-20 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Biomedical and Genetics |
$0.458B |
$0.007B |
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
|